Morning Market Movers By: Benzinga via Benzinga October 02, 2014 at 09:44 AM EDT Esperion Therapeutics (NASDAQ: ESPR) shares climbed 18.55% to $28.95 after the company announced positive top-line Phase 2b results for ... Read More >> Related Stocks: Bassett Furniture Esperion Theraptc Tesla, Inc.